Skip to main content
. 2022 Jan 18;10(2):141. doi: 10.3390/vaccines10020141

Table 1.

Characteristics of the study population including vaccination and serology status.

N (%) Mean ± Standard
Deviation (SD)
Range
Age (years) 43.94 ± 11.30 21–77
Gender Female 535 (67.50)
Male 258 (32.50)
Serology for anti-S-RBD Positive 791 (99.75)
Negative 2 (0.25)
No. of serological evaluations 1 620 (78.19)
2 173 (21.81)
Night shift status Yes 435 (54.85)
No 358 (45.25)
SARS-CoV-2 infection Before vaccination 25 (3.15)
After vaccination 13 (1.65)
Anti S-RDB titer (U/mL) <90 days 1602.3 0–2500
91–150 days 1035.9 0–2500
>150 days 724.4 0–2500
Job task Physician 262 (33.00)
Nurse 269 (33.90)
Other HCWs * 262 (33.00)
Days elapsed between the final vaccine dose and the last serology evaluation 123 ± 65 13–253
Days between the two serology evaluations 92 ± 42 11–183

* Other HCWs include lab technicians, radiology technicians, perfusion technicians (including phlebotomists), neurophysiopathology technicians, administrative personnel, cardiocirculatory physiopathology technicians, psychologists, biologists, dieticians, dental hygienists, speech therapists, orthoptists, and pharmacists.